Opportunities and challenges for the development of “core outcome sets” in neuro-oncology

Core Outcome Sets (COS) define minimum outcomes to be measured and reported in clinical effectiveness trials for a particular health condition/health area. Despite recognition as critical to clinical research design for other health areas, none have been developed for neuro-oncology. COS development...

Descripción completa

Detalles Bibliográficos
Autores principales: Millward, Christopher P, Armstrong, Terri S, Barrington, Heather, Brodbelt, Andrew R, Bulbeck, Helen, Byrne, Anthony, Dirven, Linda, Gamble, Carrol, Grundy, Paul L, Islim, Abdurrahman I, Javadpour, Mohsen, Keshwara, Sumirat M, Krishna, Sandhya T, Mallucci, Conor L, Marson, Anthony G, McDermott, Michael W, Meling, Torstein R, Oliver, Kathy, Pizer, Barry, Plaha, Puneet, Preusser, Matthias, Santarius, Thomas, Srikandarajah, Nisaharan, Taphoorn, Martin J B, Watts, Colin, Weller, Michael, Williamson, Paula R, Zadeh, Gelareh, Zamanipoor Najafabadi, Amir H, Jenkinson, Michael D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248398/
https://www.ncbi.nlm.nih.gov/pubmed/35287168
http://dx.doi.org/10.1093/neuonc/noac062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248398/
https://www.ncbi.nlm.nih.gov/pubmed/35287168
http://dx.doi.org/10.1093/neuonc/noac062

Ejemplares similares